FIP Cats UK’s Preferred Treatment Protocol (2022)

#knowledgeispower

We have created basic visuals of the key elements of comprehensive information detailed below but strongly advise they are used together, in full context.

Based on personal experiences, a group of FIP Cats UK owners having used Bova UK FIP treatments have made a number of conclusions post-FIP treatment.

The world of FIP treatment is quickly evolving and information about legal Vet UK FIP treatment can be viewed here: 

https://icatcare.org/advice/feline-infectious-peritonitis-fip/

Armed with extensive knowledge, the FIP Cats UK owner group have discussed, at length, their now highly educated views on all aspects of FIP facing cats and owners in the UK and Australia currently (as of December 2022.)

*Australia is relevant because their FIP Vet expert Dr Malik, Sydney University was using Bova FIP medications to cure FIP cats there long before Bova UK started supplying UK Vets. 

Dr Malik also informed the UK Bova treatment protocol and was a key contributor to the current UK Vet Expert FIP Advice team’s knowledge of treatment. 

With all of this, and thousands of hours of research, the FIP Cats UK owner group have constructed what they view to be a comprehensive approach to effective testing and diagnosis, treatment and supplementation, and an approach to immune system strengthening (after all this is the reason FIP occurs in a small percentage of cats in the first place and was flagged most recently by longstanding World FIP Expert Dr Niels Pedersen in the last sentence of his November 28th 2022 FIP Update – Status of FIP treatment and prevention: https://sockfip.org/wp-content/uploads/2022/12/Status-of-FIP-treatment-in-2022-v3.pdf .)




Bova GS-441524 and Merck licensed Molnupiravir treated suspected Ocular FIP cat pre and post-treatment


Neuro FIP cat post-Bova UK FIP treatment now using PI from Vetimmune for immune system strengthening

Dry FIP cats post-Bova UK FIP treatment now using PI from Vetimmune for immune system strengthening

Bova GS-441524 and Merck licensed Molnupiravir treated suspected Ocular FIP cat now using PI from Vetimmune for immune system strengthening